Brief: Extrawell Pharmaceutical Posts FY Loss Attributable HK$162.9 Mln Versus Profit HK$129.3 Mln
28/06/2024 16:12
June 28 (Reuters) - Extrawell Pharmaceutical Holdings
Ltd 0858.HK :
* FY LOSS ATTRIBUTABLE HK$162.9 MILLION VERSUS PROFIT
HK$129.3
MILLION
* FY REVENUE HK$59.1 MILLION VERSUS HK$72.6 MILLION
Further company coverage: 0858.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million